Core Insights - 2025 is a landmark year for quantitative investment, marked by the emergence of DeepSeek, which injects disruptive AI momentum into the field [3] - The A-share market has shown a significant upward trend, with small and mid-cap stocks outperforming, as evidenced by the over 36% and 80% increases in the CSI 2000 and micro-cap indices respectively [3] - The average return for quantitative private equity products in 2025 reached 30.28%, with a geometric excess return of 10.83% [3] Quantitative Strategy Performance - The top-performing quantitative long strategy products, totaling 806, achieved returns of 44.74% and geometric excess returns of 16.46% in 2025, leading among private equity secondary strategies [4] - Other strategies such as quantitative CTA and stock market neutral also performed well, with average returns of 20.21% and 9.58% respectively [4][5] Quantitative Stock Selection - The average return for quantitative stock selection products was 42.28% in 2025, with an average excess return of 17.70% [6] - The top three products in this category were from Hainan Gaia Qingke Private Equity, Water Mill Asset, and Hanrong Investment [6] Notable Products and Managers - Hainan Gaia Qingke's product "Gaia Qingke Cattail Progress A" achieved outstanding performance, with returns exceeding ***% [7] - Hanrong Investment's "Hanrong Ansheng Progress No. 1 B" also performed well, with returns exceeding ***% [8] - Longqi Technology's "Longqi Technology Innovation Selected No. 1 C" led the quantitative stock selection products with returns exceeding ***% [9] CSI 500 Index Enhancement - The average return for CSI 500 index enhancement products was 46.32% in 2025, with an average excess return of 12.22% [10] - The top three products in this category were from Guobiao Asset, Zhaoxin Private Equity Fund, and Zhaoyue Private Equity [10] CSI 1000 Index Enhancement - The average return for CSI 1000 index enhancement products was 49.68% in 2025, with an average excess return of 17.41% [14] - The top three products were from Jintong Investment, Luxiu Investment, and Mengxi Investment [14] Other Index Enhancements - The average return for other index enhancement products was 46.76% in 2025, with an average excess return of 19.95% [23] - The top three products in this category were from Jing Shang Jia Wan, Zhongmin Huijin, and Yang Shi Asset [24]

Core Insights - The A-share market recovery in 2025 has led to outstanding performance in quantitative index enhancement strategies, with an average return of 45.08% across nearly a thousand products, and almost 90% achieving positive excess returns [1][2] - The small and mid-cap index enhancement strategies have significantly outperformed, particularly the CSI 1000 index enhancement products, which achieved an average return of 49.78% [2][3] - The integration of AI technology into strategy development has become a mainstream trend in the industry, with a focus on multi-strategy and multi-frequency collaboration [6][8] Performance Highlights - The average excess return for quantitative index enhancement products in 2025 was 16.75%, with the CSI 1000 index enhancement products showing an average excess return of 17.49% [2][3] - Large-scale private equity firms with over 10 billion yuan in assets under management achieved an average return of 50.61% and an excess return of 20.26%, indicating a clear performance differentiation in the industry [3][8] - The trend of "double ten" institutions, which have been established for over ten years and have products with net values exceeding 10 yuan, has been notable, with some achieving significant growth [3] Market Dynamics - The fundraising environment for quantitative private equity has shown a dichotomy, with larger firms attracting more capital while smaller firms face increasing challenges [4][5] - A significant increase in dividend distributions has been observed, with a total of 1,658 distributions amounting to over 17.3 billion yuan, marking a 236.59% increase from the previous year [5] - The industry is witnessing a shift towards simpler models in strategy development, moving away from complex models to enhance effectiveness [5][6] Future Outlook - The industry outlook for 2026 is cautiously optimistic, with expectations of continued structural opportunities in small and mid-cap index enhancement strategies [7][8] - Challenges such as strategy crowding and market style shifts are anticipated, which may impact excess returns [7] - The trend of deepening the Matthew effect suggests that leading firms will continue to dominate, while smaller firms must differentiate their strategies to remain competitive [8]

Core Insights - The A-share market recovery in 2025 has led to outstanding performance in quantitative index enhancement strategies, with an average return of 45.08% across nearly a thousand products, and almost 90% of these products achieving positive excess returns [1][2] - The small-cap index enhancement strategies have significantly outperformed, particularly the CSI 1000 index enhancement products, which achieved an average return of 49.78% and a 95.93% positive excess return rate [2] - The industry is witnessing a "Matthew Effect," where larger firms with over 10 billion yuan in assets under management are dominating performance metrics, achieving an average return of 50.61% and a 96.65% positive excess return rate [3] Performance Analysis - In 2025, the average excess return for CSI 1000 index enhancement strategies reached 29.48%, outperforming the CSI 500 and CSI 300 index enhancements [2] - The performance disparity is attributed to structural market dynamics, with small-cap index enhancement products consistently outperforming large-cap varieties [2][3] - The top-tier private equity firms have shown a significant increase in both performance and scale, with many achieving returns exceeding 40% [3] Fundraising and Distribution Trends - The fundraising environment in 2025 has shown a dichotomy, with top-tier firms attracting more capital while smaller firms face increasing challenges [4] - A notable trend is the unprecedented wave of distributions, with private equity firms distributing over 173 billion yuan, a 236.59% increase from the previous year [4] - The focus on long-term stability and risk management has become crucial for attracting investor capital [4] Strategy Innovation - The industry is experiencing a wave of strategy innovation, with new products like micro-index enhancements and technology-themed enhancements emerging [5] - The integration of AI technology has become essential, shifting from optional to mandatory in strategy development [5][6] - Firms are increasingly adopting simpler models rather than complex ones, focusing on effective alpha capture through diverse data sources [6] Market Outlook - The outlook for 2026 is cautiously optimistic, with expectations of continued structural opportunities in small-cap index enhancements despite potential challenges from strategy crowding and market style shifts [6][7] - The industry is expected to evolve towards more diversified and refined strategies, with a growing demand for multi-asset and multi-strategy products [7][8] - The trend towards increased technical investment and a more mature investor structure suggests a positive long-term development trajectory for the quantitative investment sector [8]

Core Insights - The quantitative index enhancement strategies performed exceptionally well in 2025, with an average return of 45.08%, and nearly 90% of products achieving positive excess returns [1][2][3] Performance Overview - The average excess return for quantitative index enhancement products reached 16.75%, with small-cap index enhancement strategies leading the performance [2] - The CSI 1000 index enhancement products had an average return of 49.78% and an excess return of 17.49%, with 95.93% of products achieving positive excess returns [2] - Large-cap indices like CSI 300 had a lower average return of 31.22%, despite having the highest positive excess return ratio at 97.14% [2][3] Market Dynamics - The A-share market saw high turnover rates and average daily trading volumes, benefiting quantitative strategies [2] - The performance divergence reflects a structural change in market styles, with small-cap index enhancement products outperforming large-cap ones [3] Industry Trends - The industry experienced a significant increase in dividend distributions, with a total of 1,658 dividends amounting to over 17.3 billion yuan, a 236.59% increase from 2024 [5][6] - The trend of strategy innovation is evident, with new products like micro-index enhancements and technology-themed enhancements emerging [6][7] Future Outlook - For 2026, the industry anticipates continued structural opportunities in quantitative index enhancement strategies, although challenges such as strategy crowding and style switching are expected [8][9] - The head institutions are likely to dominate the market due to their technological, talent, and brand advantages, while smaller institutions may need to focus on differentiation [9][10]

Core Viewpoint - In 2025, index-enhanced products are expected to experience significant excess returns, driven by factors such as a daily trading volume of 1.7 trillion yuan in the Shanghai and Shenzhen markets, advancements in AI technology enhancing alpha extraction capabilities, and a favorable style for small and mid-cap indices [2] Summary by Category Performance of Index-Enhanced Products - A total of 471 index-enhanced products are projected for 2025, with an average return of 46.47% and an average excess return of 15.56% [2][4] - Among these, 177 products from private equity firms with over 10 billion yuan in assets have the highest average return of 49.05% and an average excess return of 17.45% [4] Performance by Strategy - The top-performing strategies in 2025 include: - Quantitative stock selection with an average excess return of 28.29% and an average return of 55.06% [6] - CSI 1000 index enhancement with an average excess return of 21.24% and an average return of 54.56% [5][6] - CSI 500 index enhancement with an average excess return of 15.80% and an average return of 50.99% [13][6] Top Products in Each Category - For the CSI 1000 index enhancement, the top products are managed by: - Mengxi Investment with an outstanding performance [8][12] - Mingyuan Investment and Square Investment also rank highly [8] - In the CSI 500 index enhancement category, the leading products are managed by: - Wanyan Asset and Mingyuan Fund [13][16] - Other index-enhanced products are led by: - Yanfu Investment with significant returns [19][20] Notable Managers and Firms - Mengxi Investment's Li Xiang emphasizes the transformative impact of AI on investment strategies, focusing on data processing and model optimization [12] - Mingyuan Investment, known for its application of AI in finance, maintains a strong position in the quantitative investment sector [12] - Wanyan Asset's Jin Teng has extensive experience in quantitative research and investment management [16][18] - Yanfu Investment's Gao Kang, a former researcher at Two Sigma, leads the top-performing small-cap index enhancement product [24] Market Trends and Insights - The small-cap stock style is expected to dominate in 2025, contributing to the strong performance of the CSI 1000 index enhancement products [5] - The overall market environment, characterized by high liquidity and technological advancements, is conducive to achieving high excess returns in index-enhanced products [2]

Core Insights - Deepseek has emerged as a significant player in the global AI landscape, revitalizing the quantitative investment sector, particularly in a market environment favoring small and mid-cap stocks [2] - In November, despite an overall adjustment in the A-share market, many quantitative products from billion-yuan private equity firms achieved historical highs, with quantitative products accounting for over 80% of these successes [2] - The average return for 1,833 quantitative products this year is 26.98%, with an excess (geometric) return of 11.41% [2][3] Quantitative Investment Performance - The average return for quantitative long strategies is 40.34%, with an excess return of 17.25%, making it the top performer among secondary strategies [3] - The performance of various quantitative strategies is summarized as follows: - Quantitative CTA: 16.32% average return, 13.76% excess return - Stock market neutral: 9.37% average return, -4.93% excess return - Composite strategies: 23.85% average return, 7.61% excess return - Options strategies: 11.04% average return, 8.60% excess return - Convertible bond trading strategies: 20.42% average return, 3.65% excess return - Arbitrage strategies: 11.63% average return, -2.96% excess return - Macro strategies: 21.72% average return, 5.69% excess return - Stock long-short: 15.05% average return, 0.01% excess return - FOF: 13.50% average return, -1.33% excess return - Bond composite strategies: 13.88% average return, 13.15% excess return - Pure bond strategies: 6.47% average return, 5.79% excess return - Other derivative strategies: 37.74% average return, 34.72% excess return - Bond enhancement: 11.47% average return, 10.76% excess return [3] Top Performing Quantitative Products - The "quantitative stock selection" products have an average return of 39.40% and an average excess return of 19.14% [4] - The top three products in the "quantitative stock selection" category are from: - Zhuhai Zhengfeng Private Equity - Shui Du Quan Asset - Jiu Ming Investment [5] - The "CSI 500 index enhancement" products have an average return of 40.17% and an average excess return of 14.14% [8] - The top three products in the "CSI 500 index enhancement" category are from: - Zhaoxin Private Equity Fund - Guobiao Asset - Zhaoyue Private Equity [9] - The "CSI 1000 index enhancement" products have an average return of 44.68% and an average excess return of 17.53% [13] - The top three products in the "CSI 1000 index enhancement" category are from: - Jintong Investment - Luxiu Investment - Mengxi Investment [13] Other Notable Strategies - The "CSI 300 index enhancement" products have an average return of 24.47% and an average excess return of 8.20% [17] - The top three products in the "CSI 300 index enhancement" category are from: - Hainan Pengpai Private Equity - Ningbo Huansheng Quantitative - Mingyun Investment [17] - The "other index enhancement" products have an average return of 42.58% and an average excess return of 20.13% [20] - The top three products in the "other index enhancement" category are from: - Yangshi Asset - Luxiu Investment - Shengguanda [21]

Core Viewpoint - Quantitative products are systematic investment methods based on mathematical models, algorithms, and computer technology, with the ability to generate excess returns being a key indicator of their effectiveness [2] Group 1: Quantitative Excess Rate - The quantitative excess rate is defined as the frequency or probability of a quantitative strategy outperforming a benchmark index over a certain period, calculated as the number of times it beats the benchmark divided by the total observation periods [2] - A higher quantitative excess rate indicates that the strategy can maintain positive excess returns most of the time, reducing the risk of significant drawdowns or prolonged underperformance [2] Group 2: Performance of Billion-Level Quantitative Private Equity - In 2023, 388 quantitative products from billion-level private equity firms achieved an average return of 34.26%, with an excess return of 10.87% and an average excess rate of 61.33%, significantly leading among various scales of private equity [3] - The average performance metrics for different scales of private equity are as follows: - 100 billion and above: 34.26% return, 10.87% excess, 61.33% excess rate - 50-100 billion: 25.20% return, 8.14% excess, 56.48% excess rate - 20-50 billion: 27.19% return, 10.77% excess, 55.91% excess rate - 10-20 billion: 26.56% return, 8.95% excess, 54.63% excess rate - 5-10 billion: 26.05% return, 8.99% excess, 53.59% excess rate - 0-5 billion: 24.37% return, 10.11% excess, 52.63% excess rate - Total: 27.64% return, 9.90% excess, 55.86% excess rate [3] Group 3: Top Performers in Quantitative Strategies - The top three products with the highest excess rates in the CSI 300 index enhancement category are from Minghuo Investment, Ningbo Huanfang Quantitative, and Kuande Private Equity, with the average excess rate for billion-level private equity in this category being 64.59% [4] - In the CSI 500 index enhancement category, the top three products are from Wanyan Asset, Pansong Asset, and Tianyan Capital, with an average excess rate of 67.28% for billion-level private equity [10] - In the CSI 1000 index enhancement category, the top three products are from Microbo Yi, Mengxi Investment, and Yanfeng Investment, with an average excess rate of 76.17% for billion-level private equity [10] Group 4: Quantitative Stock Selection - The average return for quantitative stock selection products in 2023 is 40.45%, with an excess return of 16.55% and an average excess rate of 58.26%, while billion-level private equity in this category has an average excess rate of 65.97% [13] - The top three products in this category are from Jiukun Investment, Tianyan Capital, and Longqi Technology [13]

Core Insights - The A-share market has entered a volatile rotation phase since October, with significant recovery in the returns of quantitative products [2] - Among the 825 quantitative long products with performance data, the average return for the year is 41.02%, with an excess return of 14.36% [3] Summary by Category Performance of Strategies - Quantitative long products have the highest average return in October among all stock strategy products, reaching 0.93% with an average excess return of 1.5% [2] - The performance of various strategies is as follows: - Quantitative long: 825 products, average return 41.02%, monthly return 0.93% [3] - Subjective long: 2156 products, average return 36.11%, monthly return -1.35% [3] - Macro strategy: 201 products, average return 27.17%, monthly return 0.96% [3] - Composite strategy: 409 products, average return 25.66%, monthly return 1.11% [3] - Other derivative strategies: 15 products, average return 25.63%, monthly return 4.45% [3] Top Performing Products - In the quantitative long category, the top products by excess return include: - CSI 1000 index enhancement: 158 products, average return 45.51%, excess return 15.48% [4] - Quantitative stock selection: 329 products, average return 39.25%, excess return 15.56% [4] - CSI 500 index enhancement: 201 products, average return 42.07%, excess return 10.96% [4] - CSI 300 index enhancement: 38 products, average return 25.62%, excess return 6.52% [4] - Other index enhancements: average return 43.55%, excess return 18.52% [4] Notable Fund Managers - The top products in the CSI 1000 index enhancement category are managed by notable fund managers from large private equity firms, with the highest returns coming from companies like Jintong Investment and Luxiu Investment [5][9] - In the quantitative stock selection category, the top products are managed by firms such as Longqi Technology and Jiuming Investment [10][12] - The CSI 500 index enhancement products are led by managers from Guobiao Asset and Zhaoxin Private Fund [13][16] - The CSI 300 index enhancement products are managed by firms like Hainan Pengpai Private Fund and Ningbo Huansquare Quantitative [17][20] - Other index enhancement products are managed by firms such as Liangchuang Investment and Yangshi Asset [21][23]

Group 1 - The market has shown a clear preference for small and micro-cap stocks this year, with the CSI 2000 index rising over 25% and the micro-cap stock sector increasing over 65% [1] - Quantitative private equity products focused on small and mid-cap stocks have performed exceptionally well, with an average return of 15.04% for 1,529 qualifying quantitative products from January to July [1][3] - The best-performing strategies among private equity products include "Other Index Increase" with an average return of 28.84% and "CSI 1000 Index Increase" with 27.00% [3] Group 2 - As of July 2025, quantitative private equity firms managing over 100 billion yuan had an average return of 20.53%, showcasing their strategic and risk management advantages [4] - The top three firms in this category are Stable Investment, Abama Investment, and Tianyan Capital, with average returns of ***%, ***%, and ***% respectively [4] - Stable Investment, founded in 2014, has a strong focus on quantitative trading across various asset classes and has developed a unique research methodology based on AI and machine learning [7][8] Group 3 - In the 50-100 billion yuan category, Tianxuan Quantitative leads with an average return of 14.27%, followed by Mingxi Asset and Jiashi Dayan [10] - Tianxuan Quantitative, established in 2014, utilizes AI technology for stock and futures quantitative investment, with a team comprising graduates from prestigious universities [12][13] Group 4 - The 20-50 billion yuan category is led by Yunqi Quantitative, with an average return of ***%, followed by Xiangmu Asset and Guangzhou Shouzheng Yiqi [16] - Yunqi Quantitative, founded in 2021, employs multi-factor stock selection and dynamic risk control strategies [16] Group 5 - In the 10-20 billion yuan category, Shanghai Zijie Private Equity tops the list with an average return of ***%, followed by Yanhui Investment and Yangshi Asset [17][19] - Shanghai Zijie Private Equity, established in 2015, focuses on quantitative hedging and value investing [19] Group 6 - The 5-10 billion yuan category is led by Liangchuang Investment with an average return of ***%, followed by Wuliang Capital and Shanghai Hanhong Private Equity [20] - Liangchuang Investment, founded in 2016, covers a wide range of asset classes and has developed proprietary trading and risk management systems [22] Group 7 - In the 0-5 billion yuan category, Quancheng Fund ranks first with an average return of ***%, followed by Hangzhou Jinshi Asset and Guangzhou Tiantianhan [23][26] - Quancheng Fund, established in 2021, focuses on secondary market investments and employs a data-driven approach to trading [26]

Core Insights - The performance of index-enhanced private equity products was outstanding in the first half of 2025, with an average return of 17.32% and an average excess return of 14.17% across 705 products, indicating that nearly all products outperformed their benchmark indices [1][2]. Group 1: Performance by Scale - Large-scale private equity (over 5 billion) showed a significant advantage, with 267 products achieving an average return of 18.3% and an average excess return of 14.51%, where 265 products had positive excess returns, accounting for 99.25% [2][3]. - Medium-scale private equity (20 to 50 billion) had 152 products with an average return of 17.3% and an average excess return of 14.37%, with 96.71% of products showing positive excess returns [3]. - Small-scale private equity (0 to 10 billion) had 286 products with an average return of 16.41% and an average excess return of 13.75%, with 89.51% of products achieving positive excess returns [3]. Group 2: Market Trends and Strategies - The market exhibited a significant small-cap style dominance, which positively impacted the performance of index-enhanced products linked to small-cap indices, with 76 other index-enhanced products and 258 air index-enhanced products achieving average returns of 20.84% and 17.88%, respectively [3]. - The performance of CSI 300 index-enhanced products lagged, with an average return of 6.31% and an average excess return of 6.28%, reflecting the overall weak performance of the CSI 300 index [4]. - Factors contributing to the strong performance of index-enhanced private equity products included structural characteristics of the A-share market, high individual stock volatility, and favorable trading conditions due to high average daily trading volume [4][5]. Group 3: Regulatory Environment - The relaxation of merger and acquisition policies by regulatory authorities led to an increase in significant asset restructuring cases, boosting market confidence and improving liquidity, which provided favorable conditions for the implementation of quantitative strategies [5].